Sherman A D, Mott J
Neuropharmacology. 1984 Nov;23(11):1253-9. doi: 10.1016/0028-3908(84)90041-8.
In studies designed to assess the pre-synaptic effects of neuroleptics in vitro, synaptosomes were prepared from several regions of rat brain. These preparations were incubated in the presence of a representative of each of the major classes of neuroleptic--chlorpromazine, haloperidol, or clozapine, or with (+) or (-)butaclamol. The calcium-specific release of endogenous glutamic acid was reduced only in synaptosomes derived from the amygdala. In this area, each of these agents [except (-)butaclamol] reduced the release of glutamic acid to a maximum of 40% in a concentration-dependent manner. When [3H]glutamine was included in the incubation media, a reduction in the released [3H]glutamate was present with 10(-8) M haloperidol, and 5 X 10(-8) M (+)butaclamol, clozapine, or chlorpromazine. (-)Butaclamol was inactive at 10(-5) M, a concentration producing complete blockade of the release of [3H]glutamic acid when active agents were included. Again, the effects were observed only in the amygdala. All agents, including (-)butaclamol blocked the uptake of [3H]glutamine into depolarized synaptosomes.
在旨在评估抗精神病药物体外突触前效应的研究中,从大鼠脑的几个区域制备了突触体。这些制剂在每种主要抗精神病药物的代表物——氯丙嗪、氟哌啶醇或氯氮平,或与(+)或(-)布他拉莫存在的情况下进行孵育。内源性谷氨酸的钙特异性释放仅在杏仁核来源的突触体中减少。在该区域,这些药物中的每一种(除了(-)布他拉莫)都以浓度依赖性方式将谷氨酸的释放减少至最大40%。当孵育培养基中含有[3H]谷氨酰胺时,10(-8)M氟哌啶醇、5×10(-8)M(+)布他拉莫、氯氮平或氯丙嗪会使释放的[3H]谷氨酸减少。(-)布他拉莫在10(-5)M时无活性,而当含有活性药物时,该浓度会完全阻断[3H]谷氨酸的释放。同样,这些效应仅在杏仁核中观察到。所有药物,包括(-)布他拉莫,都阻断了[3H]谷氨酰胺进入去极化突触体的摄取。